Quintiles ranks #1 in contract research revenues based on 1996 earnings estimates, CEO says.
Executive Summary
QUINTILES $517 MIL. REVENUES IN 1996 IS TOP IN CRO GROUP, Quintiles CEO Dennis Gillings maintained at Hambrecht & Quist's health care conference Jan. 7 in San Francisco. The total sales figure takes into account revenues generated from subsidiaries acquired during the year, including the Innovex peri-launch marketing organization, the medical device consultants BRI and the health policy firm Lewin. Corning's CRO spin-off, Covance, ranks second by 1996 revenue estimates, at about $490 mil.